Am J Cardiovasc Drugs. 2008;8(4):243-55. Review.
Kolovou GD, Kostakou PM, Anagnostopoulou KK, Cokkinos DV.

The main target of fibrate therapy is to improve fasting hypertriglyceridemia, which is an essential component associated with improving postprandial lipemia. Fibrates are well tolerated by patients and adverse effects have been reported rarely after their administration.

https://link.springer.com/article/10.2165%2F00129784-200808040-00004